Advanced Search

 

Study ID Status Title Patient Level Data
S3A40022 Completed Open-label multicentre-study to evaluate efficacy and tolerability of a novel fast-dissolving formulation of ondansetron to prevent nausea and vomiting after therapy with non-platinum-containing chemotherapy in paediatric patients.
S3A40065 Completed A Randomized, Double-Blind, Placebo-Controlled Dose Range Evaluation of Oral GR 38032F in the Prevention of Nausea and Vomiting Associated With Non-Cisplatin Chemotherapy
S3A40068 Completed Randomised, double-blind, placebo-controlled, multicentre, parallel group study to evaluate the efficacy and safety of a Zofran iv in the prevention of PONV in major gynaecological surgery.
S3A40069 Completed Randomised single centre double-blind study to compare the efficacy and safety of a single iv dose of Zofran administered either prior to induction or prior to cessation of anaesthesia in the prevention of PONV in patients having general anaesthesia and undergoing major surgery.
S3A40092 Completed A randomized, double blind, parallel group study to compare the efficacy and tolerability of ondansetron vs metoclopramide in the prevention of post-operative nausea and vomiting in patients undergoing ophthalmic surgery
S3A40095 Completed An assessment of the effect of schedule and maintenance on the antiemetic efficacy and safety of ondansetron combined with dexamethasone as acute and maintenance therapy in patients receiving moderately emetogenic chemotherapy.
S3A40121 Completed A Multicentre Double-Blind Crossover Study to Compare the Efficacy and Safety of GR38032F with Metoclopramide in the Prophylaxis of Acute Nausea and Vomiting Induced by Cisplatin-Containing Cancer Chemotherapy Regimens
S3A40125 Completed A randomised double-blind multicentre study to compare the clinical efficacy and safety of ondansetron (GR38032) and prochlorperazine in the prophylaxis of nausea and vomiting caused by fractionated radiotherapy
S3A40128 Completed A Randomised, Double-blind Study to Compare the Efficacy and Safety of Ondansetron (GR38032) Administered as Either a Single IV Dose or a Continuous Infusion Over 24 hours In Acute Cisplatin-induced Emesis
S3A40131 Completed An open non-comparative single centre study to assess the efficacy and safety of ondansetron in the prophylaxis of cancer chemotherapy-induced nausea and vomiting in children.
S3A40168 Completed A Randomized, Double-Blind, Placebo-Controlled Evaluation of Efficacy and Pharmacokinetic Parameters of Oral Ondansetron in the Prevention of Nausea and Vomiting Associated With Fractionated Total Body Irradiation
S3A40169 Completed An Open-Label Evaluation of Ondansetron Versus Ondansetron Plus Dexamethasone and Chlorpromazine in the Prevention of Nausea and Vomiting Associated with Multiple-Day Cisplatin Chemotherapy
S3A40175 Completed A single blind, placebo-controlled, multicentre study of intravenous ondansetron in the prevention of post-operative emesis (retching and vomiting) in paediatric patients undergoing strabismus surgery.
S3A40181 Completed A Randomized, Double-Blind Comparison of Oral Ondansetron and Compazine® Spansules® in the Prevention of Nausea and Vomiting Associated With Non-Cisplatin Chemotherapy
S3A40182 Completed A Stratified, Randomized, Double-Blind Comparison of Intravenous Ondansetron Administered as a Multiple Dose Regimen Versus Two Single Dose Regimens in the Prevention of Cisplatin-Induced Nausea and Vomiting
S3A40206 Completed A double-blind, placebo-controlled multicentre study of intravenous ondansetron in the prevention of post-operative emesis (retching and vomiting) in paediatric patients undergoing strabismus surgery
S3A40231 Completed A Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Ondansetron Versus Droperidol for the Prevention of Postoperative Nausea and Vomiting in Outpatient Surgery
S3A40232 Completed An Open-Label Study of IV Ondansetron Plus Dexamethasone for the Prevention of Emesis Associated with Different Degrees of Emetogenic Chemotherapy
S3A40240 Completed A randomised, double-blind, parallel group study to compare the efficacy and safety of ondansetron (GR38032F) plus dexamethasone with metoclopramide plus dexamethasone in the prophylaxis of nausea and emesis induced by carboplatin chemotherapy.
S3A40241 Completed A Randomised, Double-Blind, Parallel Group Study to Compare the Efficacy and Safety of Ondansetron plus Dexamethasone, Ondansetron and Tropisetron in the Control of Acute Cisplatin-induced Nausea and Emesis
S3A40262 Completed A randomized, double-blind, placebo-controlled, multi-center study of intravenous ondansetron for the prevention of postoperative emesis in pediatric patients undergoing outpatient surgery.
S3A40275 Completed A Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Ondansetron Versus Droperidol for the Prevention of Postoperative Nausea and Vomiting in Outpatient Surgery.
S3A40284 Completed A randomised double-blind, placebo-controlled, multicentre study to evaluate the efficacy and safety of a single intravenous dose of Ondansetron in the prevention of post-operative nausea and emesis in paediatric patients having general anaesthesia and undergoing surgery for tonsillectomy with o ...
S3A40317 Completed A randomised, double-blind, placebo-controlled multicentre parallel-group study to compare the efficacy and safety of a single intravenous bolus dose of ondansetron, metoclopramide and placebo in the prevention of postoperative nausea and emesis in patients having general anaesthesia and undergo ...
S3A40318 Completed A double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of single doses of orally administered ondansetron in the prevention of post-operative nausea and vomiting in patients having general anaesthesia and undergoing major gynaecological surgery

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.